Ramsingh G, Mehan P, Luo J, Vij R, Morgensztern D (2009) Primary plasma cell leukemia: a surveillance, epidemiology, end results database analysis between 1973, 2004. Cancer 115(24):5734–5739Ramsingh G, Mehan P, Luo J, et al. Primary plasma cell leucemia. A surveillance, ...
3) plasma cell leukemia 浆细胞白血病 1. ObjectiveTo study the features of plasma cell leukemia(PCL). 目的探讨浆细胞白血病(plasma cell leuremia, PCL)的疾病性质。 2. This study was aimed to investigate the deletion features of chromosome 13 in plasma cell leukemia(PCL) and its relationship ...
Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many novel drugs have revolutionized the treatment algorithms for MM. The impact of targeted therapy, both pre- and post-autologous stem cell ...
To determine whether primary plasma cell leukemia (PPCL) remains a high-risk multiple myeloma feature in the context of contemporary therapy and gene-expression profiling (GEP), we reviewed records of 1474 patients with myeloma, who were enrolled in Total Therapy protocols or treated identically off...
网络原发性浆细胞白血病 网络释义 1. 原发性浆细胞白血病 句子翻译_专业词汇在线翻译 ...primary plasma cell leukemia原发性浆细胞白血病primary production 初级生产力 ... www.juyy.net|基于 1 个网页 例句
Primary plasma cell leukemia presenting as secondary pulmonary alveolar proteinosisPrimary plasma cell leukemia presenting as secondary pulmonary alveolar proteinosisAristea-Maria PapanotaIoannis Ntanasis-StathopoulosAliki LiakeaEfstathios KastritisEvangelos TerposMe...
Primary plasma cell leukemia (PPCL) is a rare hematologic malignancy characterized by the proliferation of plasma cells in blood, bone marrow, and other organs in the absence of established multiple myeloma. PPCL has a poor prognosis when treated with conventional therapy for multiple myeloma. We ...
cellleukemiaBackground: The best therapeutic approach for primary plasma cell leukemia (PPCL) remains unknown so far. In very limited studies, the poor clinical outcome of this aggressive variant of multiple myeloma seemed to be ameliorated by the use of the proteasome inhibitor bortezomib. Aiming ...
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia 来自 万方 喜欢 0 阅读量: 34 摘要: Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied ...
Only one case of primary non-secretory plasma cell leukemia with atypical morphology has been reported thus far. Here we report another such case of plasma cell leukemia diagnosed on fl ow cytometry, as morphological heterogeneity and lack of monoclonal immunoglobulins in both serum and urine, made...